Fig. 1From: Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancerFlow chart for patients’ enrollment and treatment. *Follow-up examinations were performed every 2 months, including thoracic and abdominal CT scan, brain MRI scanBack to article page